Aaron K. Sato, Ph.D.

Company: Twist Bioscience

Job title: Chief Scientific Officer

Seminars:

Writing the Future of Cell Therapies using the Twist Biopharma Library of Libraries 11:15 am

Utilising its proprietary DNA technology to write synthetic libraries, Twist Biopharma provides end-to-end antibody and TCR discovery libraries including both (1) highly diverse synthetic naïve scFv and VHH antibody phage display libraries to discover targeting domains for CAR-T constructs, and (2) combinatorically assembled TCR libraries from gene fragments In this talk, Aaron Sato, CSO, will…Read more

day: Day 2 - Track A - Morning